$3.18
-0.14-4.22%
At close: -
$3.19
0.009900.31%
After Hours: Jan 31, 4:46 PM EDT
Solid Biosciences reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Solid Biosciences using advanced sorting and filters.
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q3 | 2024-11-06 | $-0.79 | $-0.67 | -17.9 % |
Q2 | 2024-08-13 | $-0.61 | $-0.67 | 8.96 % |
Q1 | 2024-05-15 | $-0.64 | $-0.64 | 0.00 % |
Q4 | 2024-03-13 | $-1.00 | $-0.99 | -1.01 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Q2 | 2024-08-13 | $0 | $1.03M | -100.0 % |
Q1 | 2024-05-15 | $0 | $1.21M | -100.0 % |
Q4 | 2024-03-13 | $0 | $1.10M | -100.0 % |
Q3 | 2023-11-08 | $0 | $1.10M | -100.0 % |
Solid Biosciences (SLDB) is scheduled to report earnings on March 12, 2025. The last reported earnings were for reported on November 6, 2024 for Q3.
The Actual EPS was $-0.79, which missed the estimate of $-0.67.
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.